Quantbot Technologies’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,300
| Closed | -$701K | – | 2255 |
|
|
2022
Q3 | $701K | Buy |
10,300
+3,490
| +51% | +$192K | 0.05% | 476 |
|
|
2022
Q2 | $217K | Buy |
6,810
+5,064
| +290% | +$148K | 0.02% | 887 |
|
|
2022
Q1 | $60K | Sell |
1,746
-454
| -21% | -$13.6K | 0.01% | 1159 |
|
|
2021
Q4 | $64K | Buy |
+2,200
| New | +$68.1K | 0.01% | 971 |
|
|
2020
Q2 | – | Sell |
-358
| Closed | -$18K | – | 1530 |
|
|
2020
Q1 | $18K | Buy |
+358
| New | +$24K | 0.01% | 614 |
|
|
2019
Q3 | – | Sell |
-900
| Closed | -$47K | – | 1659 |
|
|
2019
Q2 | $47K | Buy |
+900
| New | +$51.7K | ﹤0.01% | 912 |
|
|
2018
Q4 | – | Sell |
-1,890
| Closed | -$71K | – | 1533 |
|
|
2018
Q3 | $71K | Buy |
1,890
+21
| +1% | +$930 | 0.01% | 969 |
|
|
2018
Q2 | $84K | Buy |
1,869
+1,337
| +251% | +$60.9K | 0.01% | 907 |
|
|
2018
Q1 | $25K | Sell |
532
-1,862
| -78% | -$104K | ﹤0.01% | 1052 |
|
|
2017
Q4 | $94K | Buy |
2,394
+1,788
| +295% | +$66.8K | 0.01% | 858 |
|
|
2017
Q3 | $18K | Sell |
606
-692
| -53% | -$19.5K | ﹤0.01% | 1065 |
|
|
2017
Q2 | $35K | Sell |
1,298
-2,366
| -65% | -$70.4K | ﹤0.01% | 947 |
|
|
2017
Q1 | $135K | Sell |
3,664
-206
| -5% | -$5.19K | 0.01% | 727 |
|
|
2016
Q4 | $55K | Buy |
3,870
+2,456
| +174% | +$43.1K | 0.01% | 820 |
|
|
2016
Q3 | $32K | Buy |
+1,414
| New | +$27K | ﹤0.01% | 909 |
|
Other funds holding GBT
Quantbot Technologies's GBT Position: Q4 2022 in Review
Quantbot Technologies sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 10,300 shares — an estimated $701K sold.
Quantbot Technologies first reported a position in GBT in Q3 2016 and held it in 15 quarters. The position peaked at $701K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Quantbot Technologies reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Quantbot Technologies sold 10,300 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $701K.
- Quantbot Technologies first reported a position in Global Blood Therapeutics, Inc. in Q3 2016 and held it in 15 quarters.
- Quantbot Technologies's Global Blood Therapeutics, Inc. position peaked at $701K in Q3 2022.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Quantbot Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.